Home

Topiroxostat

Topiroxostat

Specifications

577778-58-6CAS Number
4-(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)pyridine-2-carbonitrileIUPAC Name
C13H8N6Chemical Formula
248.24 g/molMolecular Weight
Topiroxostat; 577778-58-6; 4-(5-PYRIDIN-4-YL-1H-1,2,4-TRIAZOL-3-YL)PYRIDINE-2-CARBONITRILE; FYX-051; uriadec; 0J877412JV; 4-(5-(Pyridin-4-yl)-1h-1,2,4-triazol-3-yl)pyridine-2-carbonitrile; DTXSID80206462; 4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile; 4-(5-pyridin-4-yl-1H-(1,2,4) triazol-3-yl)pyridine-2-carbonitrile; topiroxostatum; RefChem:898615; DTXCID80128953; FYX 051; topiloric; Topiroxostat [INN]; MFCD17167057; 4-(3-(Pyridin-4-yl)-1H-1,2,4-triazol-5-yl)picolinonitrile; 4-(5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl)picolinonitrile; CHEMBL1078685; 5-(2-cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazole; 4-[5-(4-Pyridyl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile; 2-Pyridinecarbonitrile, 4-[5-(4-pyridinyl)-1H-1,2,4-triazol-3-yl]-; UNII-0J877412JV; Uriadec (TN); Topiroxostat (Standard); Topiroxostat (JAN/INN); TOPIROXOSTAT [MI]; TOPIROXOSTAT [JAN]; Topiroxostat(FYX-051)?; SCHEMBL860420; TOPIROXOSTAT [WHO-DD]; orb1305544; SCHEMBL4680577; SCHEMBL18056618; SCHEMBL29403929; GTPL10592; C13H8N6; UBVZQGOVTLIHLH-UHFFFAOYSA-N; GLXC-06067; HMS5082G03; EX-A1197; BDBM50267750; BDBM50311275; HY-14874R; MSK160033; s3719; 4-[5-PYRIDIN-4-YL-1H-[1,2,4]TRIAZOL-3-YL]-PYRIDINE-2-CARBONITRILE; AKOS026750465; AKOS026751485; CCG-266938; CS-2033; DB01685; NCGC00378610-01; NCGC00378610-02; AC-30740; AS-56359; HY-14874; SY116097; NS00070900; T2397; A11261; D09786; F511535; BRD-K77561571-001-01-1; Q15725832Synonyms